Avecia in skin tissue project

O'Driscoll, Catherine
May 2006
ICIS Chemical Business;5/1/2006, Vol. 1 Issue 17, p38
Trade Publication
The article reports on the plans of Avecia Biotechnology to take part in a project aimed at manufacturing stem cells used to make new skin tissue for burns victims in 2006. Jointly funded by Avecia and the British Department of Trade and Industry, project partners include the Centre for Stem Cell Discovery & Regenerative Medicine of the Durham University and the Blond McIndoe Centre.


Related Articles

  • Identification of p63+ keratinocyte progenitor cells in circulation and their matrix-directed differentiation to epithelial cells. Nair, Renjith P.; Krishnan, Lissy K. // Stem Cell Research & Therapy;2013, Vol. 4 Issue 2, p1 

    Introduction: In the event of chronic diabetes or burn wounds, accomplishing skin regeneration is a major concern. Autologous skin grafting is the most effective remedy, but the tissue harvest may create more nonhealing wounds. Currently available skin substitutes have a limited clinical outcome...

  • Gene and stem cell therapy combination could aid wound healing, Hopkins researchers find.  // Transplant News;Oct2013, Vol. 23 Issue 10, p6 

    The article focuses on the study conducted by researchers at John's Hopkins University School of Medicine which examines the use of combined gene and stem cell therapy in wound healing. It says that the researchers have observed the healing process in mice with burn wounds through the increase...

  • Stem Cell Therapy: A New Treatment for Burns? Arno, Anna; Smith, Alexandra H.; Blit, Patrick H.; Shehab, Mohammed Al; Gauglitz, Gerd G.; Jeschke, Marc G. // Pharmaceuticals;Oct2011, Vol. 4 Issue 10, p1355 

    Stem cell therapy has emerged as a promising new approach in almost every medicine specialty. This vast, heterogeneous family of cells are now both naturally (embryonic and adult stem cells) or artificially obtained (induced pluripotent stem cells or iPSCs) and their fates have become...

  • Stem cell transplants favourable for acute leukaemia.  // PharmacoEconomics & Outcomes News;9/8/2007, Issue 536, p7 

    The article discusses research being done on stem cell transplantation. It references a study by V. Costa et al. published in the July-August 2007 issue of the "Value in Health." A group of researchers from Canada reported that stem cell transplantation is cost effective for the treatment of...

  • [1] Developmental outcome in five children with Hurler syndrome after stem cell transplantation: a pilot study/[2] Developmental outcomes in children with Hurler syndrome after stem cell transplantation.  // Current Medical Literature: Lysosomal Storage Disease;2008, Vol. 8 Issue 1, p27 

    The article reports on the medical study on the developmental outcomes in children with Hurler syndrome after stem cell transplantation. It states that a relative reduction in head circumference and a significant decrease in white matter lesions was found in children. It adds that the authors...

  • Stem cell research-why is it regarded as a threat? Lachmann, Peter // EMBO Reports;Mar2001, Vol. 2 Issue 3, p165 

    This article focuses on the economic and ethical arguments made against research with human embryonic stem cells. It is indisputable that most novel medical technologies are expensive. However, they usually get cheaper as the scale on which they are used increases. A few decades later, bone...

  • Artificial chromosomes correct a genetic defect. Aldhous, Peter // New Scientist;6/10/2006, Vol. 190 Issue 2555, p11 

    The article offers information on a study that describes the future of gene therapy. According to Mitsuo Oshimura of Tottori University in Japan, stem cells have great potential as a tool for gene therapy because they should divide and give rise to new tissues once transplanted in the body....

  • Systemic Sclerosis.  // Current Medical Literature: Rheumatology;2006, Vol. 25 Issue 4, p97 

    The article discusses the findings of medical research on systemic sclerosis. One study assesses the efficacy of cyclophosphamide in the treatment of scleroderma lung disease. Another explores both the potential benefits and risk of allogenic hematopoetic stem cell transplantation after...

  • Supercell. Cohen, Philip // New Scientist;04/24/99, Vol. 162 Issue 2183, p32 

    Discusses research efforts involving embryonic stem cells (ESC) to create living tissue. Pluripotent human cells that make up teratocarcinomas tumors; Ability to retrieve ESC from embryos and fetuses; Ability of normal cells to spawn from more than one germ layer; Findings of Darwin Prockop and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics